Cervical precancer and cancer, past, present and future

This review is a short summary of the very long history of invasive and in situ carcinomas of the cervix. The items considered in this paper are the etiology of cervical cancer by a sexually transmitted agent proposed about 150 years ago by Domenico Rigoni Stern, the birth of radical surgery for the treatment of cervical invasive carcinoma with the Wertheim operation in 1898, radium therapy and chemotherapy, cytological diagnosis, the birth of colposcopy, microcolposcopy, the definition of carcinoma in situ, dysplasia and microcarcinoma, the birth of the International Federation for Cervical Pathology and Colposcopy, condylomatosis lesions of the cervix and some HPVs as agents of cervical pre-cancer and cancer, and finally the concept of vaccination against oncogenic HPV types. All these constitute an integral part of common medical practice.

Cervical cancer; in situ carcinoma; History

[1] Cislaghi C.: "Rilettura delle note del Dott. Rigoni-Stem sulla frequenza del cancro. Verona 1842". Epidemiologia Prevenzione, 1978, 3, 43.

[2] Wertheim E.: "Zur Frage der Radical Operation beim Uteruskrebs". Arch. Gynaek., 1900, 61, 627.

[3] Meigs J.V.: "The Wertheim operation for carcinoma of the cervix". Am. J. Obstet. Gynecol., 1945, 40, 542.

[4] Schauta F.: "Die operation des Gebaermutterkrebs mittels des Schuchardtschen Paravaginalschnittes". Geburt. Gynaek., 1902, 15, 133.

[5] Schauta F.: "Die erweiterte vaginale total exstrirpation des uterus beim kollumkarzinom". Wien & Leipzig: J. Safar, 1908.

[6] Amreich I.: "Zur anatomie und technik der erwiterted vaginalen carcinomoperation". Arch. Gynaekol., 1924, 122, 497.

[7] Dargent D.: "New future for schautas operation through pre-surgical retroperitoneal pelviscopy". Eur. J. Gynaecol. Oncol., 1987, 8, 292.

[8] Curie P., Curie M., Bemont G.: "Su r une nouvelle substance fortement radioactive contenue dans la petchblende". Compt. Rend. Acad. Sci., 1898, 127, 1215.

[9] Cheron H., Rubens-Duval H.: "Apercu sur les resultats de la radiumtherapie des cancers de !'uterus et du vagin". B,ull. Soc. Obstet. Gynec., 1913, 2, 418.

[10] Benedetti Panici P.L., Scambia G., Baiocchi G., Greggi S., Ragusa G., Gallo A. et al.: "Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival". Cancer, 1991, 67, 372.

[11] Thomas G.: "Improved treatment for cervical cancer. Concurrent chemotherapy and radiotherapy". N. Engl. J. Med., 1999, 340, 1198.

[12] Hinselmann H.: "Verbesserung der inspektionsmoglichkeiten von vulva, vagina und portio". Munch. Med. Wschr., 1925, 77, 1733.

[13] Hinselmann H.: "Einfuhrung in die Kolposkopie". Hartung, Hamburg, 1933.

[14] De Palo G., Chanen W., Dexeus S.: "Patologia y tratamiento del tracto genital inferior". Masson (ed.), Barcellona, 2000.

[15] Di Saia P.J., Creasman W.T.: "Clinical gynecologic oncology". Mosby C.V. Co., (3'• ed.). St. Louis, Washington DC, Toronto, 1989.

[16] Walton R.J.: "Report of a Task Force Reconvened by Health Service Directorate (Health Services and Promotion Branch. Govemment of Canada)： Cervical Cancer Screening Prograrns, 1982”. Ottawa, Canada,Mimster ofNational Health and Welfare, 1982.

[17] Harnou J.: "Microhysteroscopy. A new procedure and its original application in gynecology". J. Reprod. Med., 1981, 26, 375.

[18] Vecchione A., Montevecchi L.: "Microcolposcopia". In: G. De Palo (ed.): "Manuale di Colposcopia e Patologia del Tratto Genitale lnferiore". Milano, 2nd Ed., Masson, 1994.

[19] Guerra B., Guida G., Falco P., Gabrielli S., Martinelli G.M., Bovicelli L.: "Microcolposcopic topographic endocervical assessment before excisional treatment of cervical intraepithelial neoplasia". Obstet. Gynecol., 1996, 88, 77.

[20] Koss L. G.: "The Papanicolaou test for cervical cancer detection. A triumph and a tragedy". JAMA, 1989, 261, 737.

[21] Babes A.: "Diagnostique du cancer uterin par les frottis". Presse Med., 1928, 36, 451.

[22] Papanicolaou G.H., Traut H.F.: "Diagnosis of the uterine cancer by the vaginal smear". The Commonwealth Fund, New York, 1943.

[23] Ayre J.E.: "Selective cytology smear for diagnosis of cancer". Am. J. Obstet. Gynecol., 1947, 53, 609.

[24) Boon M.E., Alons-van Kordelaar J., Rietveld-Scheffers P.: "Consequences of the introduction of combined spatula and cytobrush sampling for cervical cytology. Improvements in smear quality and detection rates". Acta Cytol., 1986, 30, 264.

[25] Broders A.C.: "Carcinoma in situ contrasted with benign penetrating epithelium". JAMA, 1932, 99, 1670.

[26] Reagan J.W., Seideman LL., Saracusa Y.: "Cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix". Cancer, 1953, 6, 224.

[27] International Committee on Histological Definitions. Acta Cytol., 1962, 6, 235.

[28] Koss L.G., Stewart F.W., Foote F.W. Jordan M.J., Bader G.M., Day E.: "Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix". Cancer, 1963, 16, 1160.

[29] Richart R.M.: "Natural history of cervical intraepithelial neoplasia". Clin. Obstet. Gynecol., 1967, 10, 748.

[30] Chanen W., Hollyock V.E.: "Colposcopy and the conservative management of cervical dysplasias and carcinoma in situ". Obstet. Gynecol., 1974, 43, 527.

[31] Chanen W., Rome R.M.: "Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15 year survey". Obstet. Gynecol., 1983, 61, 673.

[32] Duncan I.D.:'The semm cold coagulator in the management of cervical intraepithelial neoplasia". Clin. Obstet. Gynecol., 1983, 26, 996.

[33] Puig-Tintore L.M., Gonzales-Merlo J., Jou P., Marquez M., Faus R.: "Treatment of CIN with the CO2 laser vaporization". Eur. J Gynaecol. Oncol., 1988, 9, 320.

[34] Dorsey J.H., Diggs E.S.: "Microsurgical conization of the cervix by carbon dioxide laser". Obstet. Gynecol., 1979, 54, 565.

[35] Prendiville W., Cullimore J., Norman S.: "Large loop excision of the transformation zone (LLETZ). A new method of manage-ment for women with cervical intraepithelial neoplasia". Br. J. Obstet. Gynaecol., 1989, 97, 1054.

[36] Ferenczy A.: "Electroconization of the cervix with a fine-needle electrode". Obstet. Gynecol., 1994, 84, 152.

[37] Anderson M.C., Hartley R.B.: "Cervical crypt involvement by intraepithelial neoplasia". Obstet. Gynecol., 1980, 55, 546.

[38] Bandieramonte G., De Palo G.: "II laser". In: G. De Palo (ed.): "Manuale di Colposcopia e Patologia de! Tratto Genitale Inferi­ore". 2''ed., Masson, Milano, 1994.

[39] Bandieramonte G., Lomonico S., Quattrone P., Stefanon B., Merola M., Bucci A.: "Laser conization assisted by crypt visualiza­tion for cervical intra-epithelial neoplasia". Obstet. Gynecol., 1998, 91, 263.

[40] Ostor A.G., Pagano R., Davoren R.A.M., Fortune D.W., Chanen W., Rome R.: "Adenocarcinoma in situ of the cervix". Int. J. Gynecol. Pathol., 1984, 3, 179.

[41] Wolf J.K., Levenback C., Malpica A., Morris M., Burke T., Mitchell M.F.: "Adenocarcinoma in situ of the cervix: significance of cone biopsy margins". Obstet. Gynecol., 1996, 88, 82

[42] Mestwerdt G.: "Die Fruhdiagnose des Kollumkarzinoms". Zbl. Gynakol., 1947, 69, 198.

[43] Creasman W.T., Zaino R.J., Major F.J., DiSaia P.J., Hatch K.D., Homesley H.D.: "Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study". Am. J. Obstet. Gynecol., 1998, 178, 62.

[44] FIGO Cancer Committee: "Staging announcement". Gynecol. Oneal., 1986, 25, 383.

[45] FIGO News: "Modifications in the staging for stage I vulvar and stage I cervical cancer. Report of the FIGO Committee on Gynecologic Oncology". Int. J. Gynecol. Obstet., 1995, 50, 215.

[46] Stafl A.: "New nomenclature for colposcopy. Report of the Committee on Terminology". Obstet. Gynecol., 1976, 48, 123.

[47] Stafl A., Wilbanks G.D.: "An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy". Obstet. Gynecol., 1991, 77, 313.

[48] Coppleson M., Pixley E., Reid B.: "Colposcopy". 2"'ed. Charles C. Thomas, Springfield, 1978.

[49] Mossetti C., De Palo G., Remotti G., Marchionni M., De Virgilis G., Montanari G.R. et al.: "Proposta di una classificazione colposcopica unificata italiana". Min. Gin., 1987, 39, 99.

[50] Walker P., Dexeus S., De Palo G., Barrasso R., Campion M., Girardi F. et al.: "International terminology of colposcopy: an update report from the International Federation for Cervical Pathology and Colposcopy". Obstet. Gynecol., 2003, 101, 175.

[51] National Cancer Institute Workshop:'The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses". JAMA, 1989, 262, 931.

[52] National Institutes of Health: "The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop." JAMA, 1992, 267, 1892.

[53] Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M. et al.: "The 2001 Bethesda System. Terminology for reporting results of cervical cytology". JAMA, 2002, 287, 2114.

[54] Koss L.G., Durfee G.R.: "Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of Koilocytotic Atypia". Ann. N.Y. Acad. Sci., 1956, 63, 1245.

[55] Meisels A., Fortin R: "Condylomatous lesions of the cervix and vagina. I. Cytologic patterns". Acta Cytol., 1976, 20, 505.

[56] Meisels A., Fortin R., Roy M.: "Condylomatous lesions of the cervix. II. A cytologic, colposcopic and histopathologic study" Acta Cytol., 1977, 21,379.

[57] Della Torre G., Pilotti S., De Palo G., Rilke F.: "Viral particles in cervical condylomatous lesions". Tumori, 1978, 64, 549.

[58] Wieland U., Pfister H.: "Papillomaviruses in human pathology: epidemiology, pathogenesis and oncogenic role. In: "Human Papilloma Virus Infection. A Clinical Atlas". Gross G., Barrasso R. (eds.), Ullstein Mosby, Berlin, 1997.

[59] Durst M., Gissmann L., Ikenberg H, zur Hausen H.: "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographics regions". Proc. Natl. Acad. Sci. USA, 1983, 80, 3812.

[60] Boshart M., Gissmann L. lkenberg H., Kleinheinz A., Scheurlen W., zur Hausen H.: "A new type of papililomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer". EMBO J., 1984, 3, 1151.

[61] Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., Zur Hausen H.: "Structure and transcription of human papillomavirus sequences in cervical carcinoma cells". Nature, 1985, 314, 111.

[62] Dyson N., Howley P.M., Munger K., Harlow E.: "The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product". Science, 1989, 243, 934.

[63] Werness B.A., Levine A.J., Howley P.M.: "Association of human papillomavirus types 16 and 18 E6 proteins with p53". Science, 1990, 248, 76.

[64] Bosch X.F., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J. et al.: "International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective". J. Natl. Cancer Inst., 1995, 87, 796.

[65] Walboomers J.M., Jacobs M.V., Manos M.M., Bosch X.F., Kummer A.J., Shah K.V, et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer world-wide". J. Pathol., 1999, 189, 12.

[66] IARC: "Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papilllomaviruses",vol. 64, Lyon, 1995.

[67] Munoz N., Bosch X., Chichareon S., Eluf-Neto J., Ngelangel C., Caceres E. et al.: "A multinational case-control study on the risk of cervical cancer liked to 25 HPV types: which are the high-risk types?" (abstr.). 18'" Int. Papilllomavirus Conference, 2000, A053.

[68] Munoz N., Bosch X.F., de Sanjose S., Herrero R., Castellsague X., Shah K. V. et al.: "Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl. J. Med., 2003, 348, 518.

[69] Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L., Delius H. et al.: "Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphims, nucleotide sequence and phylogenetic algorithms". J. Infect. Dis., 1994, 170, 1077.

[70] Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch X.F., Wheeler C.M.: "Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective". J. Viral., 1997, 71, 2463.

[71] Xi L.F., Koutsky L.A., Galloway D.A., Kuypers J., Hughes J.P., Wheeler C.M. et al.: "Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia". J. Natl. Cancer Inst., 1997, 89, 796.

[72] Borysiewicz L.K., Fiander A., Nimako M., Man S., Wilkinson W.G., Westmoreland D. et al.: "A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer". Lancet, 1996, 347, 1523.

[73] Zhou J., Sun X.Y., Stenzel D.J., Frazer l.H.: "Expression of vaccinia recombinant HPV 16 LI and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles". Virology, 1991, 185, 251.

[74] Hagensee M.E., Yaegashi N., Galloway D.A.: "Self-assembly of human papillomavirus type 1 capsids by expression of the LI protein alone or by coexpression of the LI and L2 capsid proteins". J. Viral., 1993, 67, 315.

[75] Kirnbauer R., Hubbert N.L., W heeler C.M., Becker T.M., Lowy D.R., Schiller J.T.: "A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16". J. Natl Cancer Inst., 1994, 86, 494.

[76] Breitburd F., Kirnbauer R., Hubbert N.L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G. et al.: "Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection". J. Viral., 1995, 69, 3959.

[77] Christensen N.D., Reed C.A., Cladel N.M., Han R., Kreider H.W.: "Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomaviruses". J. Virol., 1996, 70, 960.

[78] Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.l., Tamura J.K., Bell A. et al.: "Systemic immunization with papilJomavirus L 1 protein completely prevents the development of viral mucosa! papillomas". Proc. Natl. Acad. Sci USA, 1995, 92, 11553.

[791 Kirnbauer R., Chandrachud L.M., O'Neil B.W., Wagner E.R., Grindlay G.J., Armstrong A. et al.: "Virus-like particles of bovme papillomavirus type 4 in prophylactic and therapeutic immunization". Virology, 1996, 219, 37

[80] Harro C.D., Pang Y.Y.S., Roden R.B.S., Hildesheim A., Wang Z., Reynolds M.J. et al.: "Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 LI virus-like particle vaccine". J. Natl. Cancer Inst., 2001, 93, 284.

[81] Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B. et al.: "A controlled trial of a human papillomavirus type 16 vaccine". N. Engl. J. Med., 2002, 347, 1645.